Pular para o conteúdo
Merck
Todas as fotos(1)

Key Documents

View All Documentation

T-019

Supelco

(−)-11-nor-9-Carboxy-Δ9-THC solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C21H28O4
Número CAS:
56354-06-4
Peso molecular:
344.44
Número CE:
200-659-6
Número MDL:
MFCD02682121
Código UNSPSC:
41116107
ID de substância PubChem:
329826590
NACRES:
NA.24

grau

certified reference material

Nível de qualidade

300

forma

liquid

Características

Snap-N-Spike®/Snap-N-Shoot®

embalagem

ampule of 1 mL

fabricante/nome comercial

Cerilliant®

drug control

psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

concentração

1.0 mg/mL in methanol

técnica(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

adequação

suitable for immunoassay

aplicação(ões)

cannabis testing
forensics and toxicology

formato

single component solution

temperatura de armazenamento

−20°C

cadeia de caracteres SMILES

CCCCCC(C=C1O)=CC2=C1[C@@]3([H])[C@@](C(C)(C)O2)([H])CCC(C(O)=O)=C3

InChI

1S/C21H28O4/c1-4-5-6-7-13-10-17(22)19-15-12-14(20(23)24)8-9-16(15)21(2,3)25-18(19)11-13/h10-12,15-16,22H,4-9H2,1-3H3,(H,23,24)/t15-,16-/m1/s1

chave InChI

YOVRGSHRZRJTLZ-HZPDHXFCSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

11-nor-9-Carboxy-Δ9-THC is the inactive carboxylic form of 11-hydroxy-Δ9-tetrahydrocannabinol (Δ9-THC-OH), the primary oxidation bioactive metabolite of the main psychoactive component of cannabis, Δ9-Tetrahydrocannabinol (Δ9-THC).

Aplicação

The Certified Spiking Solution® is suitable for (−)-11-nor-9-Carboxy-Δ9-THC testing by HPLC, GC/MS or LC-MS/MS methods in forensic analysis, clinical toxicology, urine drug testing, and Cannabis potency or impurity profiling testing applications. The Certified Reference Material (CRM) in solution can also be used as follows:
  • Analysis of Δ9-Tetrahydrocannabinol (Δ9-THC) and its three metabolites in plasma and urine samples by gas chromatography (GC) coupled to triple quadrupole mass spectrometer
  • Development of an automated sample preparation method based on solid phase extraction (SPE) to determine ∆9-tetrahydrocannabinol (THC) and its three primary metabolites in a variety of matrices, such as serum, saliva, and urine using liquid chromatography-mass spectrometry (LC-MS)
  • Simultaneous determination of cannabinoids and their metabolites in human serum samples by an atmospheric-pressure chemical ionization gas chromatography-tandem mass spectrometry (APGC-MS/MS)
  • Multi-analysis of cannabinoids and their metabolites by gas chromatography (GC) coupled to vacuum UV spectrometry
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method-based determination of 10 cannabinoids in oral fluid samples following their solid phase extraction (SPE)
  • Multi-residue analysis of 14 drugs of abuse from different categories by solid phase extraction (SPE) and LC-MS/MS

Características e benefícios

  • Fully characterized under ISO/IEC 17025 and ISO 17034 accreditation
  • Accompanied with a comprehensive Certificate of Analysis (CoA) with data on stability, homogeneity, accuracy of concentration, uncertainty, and traceability
  • Rigorously tested through real-time stability studies to ensure accuracy and shelf life
  • Gravimetrically prepared using qualified precision balances to ensure minimal uncertainty
  • Flame sealed under argon into ampoules for long-term shelf life
  • Offered in a convenient, DEA-exempt format to improve laboratory efficiency

Informações legais

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

produto relacionado

Nº do produto
Descrição
Preços

T-003

(−)-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-004

(±)-11-nor-9-Carboxy-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-trans-Δ9-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-006

(±)-11-nor-9-Carboxy-Δ9-THC solution, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-007

(±)-11-nor-9-Carboxy-Δ9-THC-D9 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-008

(±)-11-nor-9-Carboxy-Δ9-THC-D3 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-011

(−)-Δ9-THC-D3 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-018

(−)-11-nor-9-Carboxy-Δ9-THC solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-038

(+)-11-Nor-Δ9-THC-9-carboxylic acid glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-080

(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-148

(-)-11-Nor-delta9-THC- 9-carboxylic acid glucuronide solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

Palavra indicadora

Danger

Classificações de perigo

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Órgãos-alvo

Eyes

Código de classe de armazenamento

3 - Flammable liquids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

49.5 °F - closed cup

Ponto de fulgor (°C)

9.7 °C - closed cup

Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Yannick Lecompte et al.
Journal of analytical toxicology, 36(8), 569-574 (2012-08-31)
The guidelines for screening of urinary cannabinoids require that all specimens testing positive should be confirmed by gas chromatography-mass spectrometry at a confirmatory test cutoff value of 15 ng/mL of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH). To assess the impact of lowering the confirmatory
Vanessa de M Prata et al.
Analytical and bioanalytical chemistry, 403(2), 625-632 (2012-03-01)
A new procedure is described for the derivatization by silylation of 11-nor-Δ(9)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) present in urine, followed by analysis using gas chromatography-tandem mass spectrometry. A conventional procedure for derivatization of the analyte was evaluated using two types of experimental
Iria González-Mariño et al.
Analytical chemistry, 84(3), 1708-1717 (2011-12-22)
For the first time, a mixed-mode solid-phase extraction with fractionation of basic analytes from neutral and acidic species during cartridge elution and liquid chromatography-quadrupole-time-of-flight mass spectrometry (LC-QTOF-MS) was combined for the quantitative determination of 24 illicit drugs and metabolites in
Gabriele Zanchetti et al.
Journal of mass spectrometry : JMS, 47(1), 124-130 (2012-01-28)
A method for the rapid and robust confirmation of 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid (THCA) in urine involving basic hydrolysis with NaOH and direct injection of the hydrolysate in a column-switching LC-MS-MS system was developed and validated. THCA-d3 was used as internal standard.
Cynthia Coulter et al.
Journal of analytical toxicology, 36(6), 413-417 (2012-04-26)
This paper describes the determination of tetrahydrocannabinol (THC) and its metabolite, 11-nor-Δ⁹-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in oral fluid using solid-phase extraction and liquid chromatography with tandem mass spectral detection (LC-MS-MS) and its application to proficiency specimens. The method employs collection of
Exibir todos os documentos relacionados

Protocolos

LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites in Urine on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, β-Glucuronidase Enzyme Digestion

-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material

Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine Following Optimized Enzymatic Hydrolysis Conditions

To optimize hydrolysis using β-glucuronidase, factors such as incubation time, temperature, hydrolysis pH, enzyme source, and enzyme concentration must be evaluated for each glucuronide metabolite to be analyzed.

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica